Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/135124
A role for the host in the roadmap to diabetes stem cell therapy
Journal Title
Director/Tutor
Additional contribution
Journal ISSN
Volume Title
Abstract
Stem cells represent an unlimited source for cell therapy (1), and considerable efforts have been made to overcome barriers to introducing this revolutionary therapy into clinical practice. Briefly, the following actions must be taken: 1) design in vitro differentiation strategies to generate either mature postmitotic b-cells or b-cell progenitors that may be safely implanted into the host (e.g., without uncontrolled proliferation), 2) devise selection methods to produce a pure b-cell population, 3) validate standard characterization protocols to determine the real differentiation stage of the cells ready to be transplanted, 4) obtain encapsulation devices to implant the cells, 5) develop preclinical controls in representative animal models, and 6) de fine cell-host interactions (for a recent review see ref. 2)
Related resource
Subject
Subject (English)
Citation
Citation
SORIA, Bernat, et al. A role for the host in the roadmap to diabetes stem cell therapy. Diabetes. 2016. Vol. 65, num. 5, pags. 1155-1157. ISSN 0012-1797. [consulted: 9 of October of 2026]. Available at: https://hdl.handle.net/2445/135124